Skip to the shortlist
Peptide ClarityGuide
Safety

Is NMN safe? Short-trial findings and longer-term unknowns

NMN's safety record looks good, as far as it goes. Here are the selected human safety readouts, and the questions those trials can't answer.

Mara Whitford

Heads up: Peptide Clarity Guide works with affiliate partners. Nothing on this page earns us a fee, and the order here ignores who's a partner. How we earn.

The short answer

In human trials lasting from a single dose to 24 weeks, NMN didn't cause more side effects than placebo, and lab results stayed in normal ranges. Those trials can't tell you whether NMN is safe for years, in pregnancy, alongside other medicines, or with cancer. FDA doesn't approve supplements before sale, so check with your clinician first.

Key takeaways

  • Short-term safety looks clean across at least nine human trials, from a single dose to 24 weeks.
  • One cited safety study tested 1,250 mg daily for 4 weeks in 31 healthy adults.
  • These trials do not establish NMN's interaction profile with other medicines.
  • These trials do not establish safety in pregnancy, breastfeeding, cancer or use over years.
  • NMN is sold as a supplement, so FDA doesn't check it before it reaches shelves, and quality depends on the maker.

Here's the short version. The selected trials of NMN generally report good short-term tolerability. They are too small and short to rule out uncommon or delayed harms, or establish safety in excluded groups.

What the human trials found

Across trials of a single dose up to 24 weeks, NMN was well tolerated, with no treatment-related serious side effects reported. The table summarizes selected trials.

NMN safety in human trials.
TrialPeopleLengthAmount the trial usedSafety resultSponsor or industry ties
Irie 2020 [2]10 healthy men (no placebo group)Single dose100, 250 and 500 mg, one at a timeNo significant symptoms; small lab shifts stayed in normal rangesCo-authors from Shionogi
Fukamizu 2022 [1]31 healthy adults, 20 to 654 weeks1,250 mg a dayNo changes beyond normal variation; no severe side effectsFunded by Mitsubishi Corporation Life Sciences
Okabe 2022 [3]30 healthy adults12 weeks250 mg a dayNo abnormal lab or exam resultsNMN supplied by Mitsubishi Corporation Life Sciences
Igarashi 2022 [4]Healthy older men6 or 12 weeks250 mg a dayWell tolerated, no significant harmful effectMitsubishi Corporation Life Sciences co-authors
Yi 2023 [5]80 healthy middle-aged adults60 days300, 600 or 900 mg a dayNo safety issues on adverse-event, lab and clinical checksFirst author works for Abinopharm
Pencina 2023 [6]32 adults aged 55 to 80 with overweight or obesity14 days1,000 mg of MIB-626 once or twice a daySide effects as frequent as on placeboMetro International Biotech co-authors
Katayoshi 2023 [9]36 healthy middle-aged adults12 weeks250 mg a dayWell tolerated, no side effects reportedAuthors report no competing interests
Morifuji 2024 [7]60 older adults12 weeks250 mg a dayNo side effects linked to NMNAuthors work for Meiji
Akasaka 2023 [8]14 men over 65 with diabetes24 weeks250 mg a dayTolerated, no severe side effectsNot stated in the abstract

Amounts are what each trial gave, listed so you can see what was tested. They aren't a recommended dose. All trials are placebo-controlled unless the row says otherwise.

That's a consistent picture. It's also a narrow one: a few hundred people in total, mostly healthy, and mostly in Japan.

Is NMN safe to take daily?

The cited trials include daily use for up to 24 weeks without a clear safety signal. That does not establish safety over years or exclude uncommon adverse effects.

One dedicated safety trial used 1,250 mg daily for 4 weeks [1]. The 24-week trial in this table enrolled only 14 men [8]. Pencina also tested 1,000 mg twice daily for 14 days [6]. These separate, small studies do not establish safety at high amounts for long periods.

What short, small trials can and can't catch

They can catch common, early problems; they can't catch rare or slow ones. If a side effect showed up in one person in a hundred, a 30-person trial could easily miss it.

Problems that build over years, like effects on blood vessels, organs or cancer risk, need large trials or long tracking of real-world users. The selected NMN trials do not provide that evidence. Supplements are not subject to the same premarket drug-approval process, and small trials do not resolve rare-event or long-duration risks.

Side effects people report

Trials didn't find more side effects on NMN than on placebo. In the single-dose study, heart rate, blood pressure, oxygen levels and body temperature didn't change [2].

You'll still see people describe side effects online. Individual reports cannot, by themselves, distinguish an NMN effect from another ingredient, another treatment or coincidence. If something feels off after you start, stop and tell your clinician.

Who should be careful, or skip it

The selected studies do not establish safety for pregnancy, breastfeeding, cancer treatment, or combinations with other medicines. Ask a clinician first.

  • Pregnancy and breastfeeding: the studies summarized here do not establish safety.
  • Cancer: none of the trials above reported a cancer signal, but they were far too small and short to detect one. If you have cancer or are being treated for it, that's a conversation with your oncologist.
  • Long-term conditions: the table includes one small trial in older men with diabetes [8]. That does not establish safety across kidney, liver or heart conditions.
  • Teens and children: these adult trials do not establish pediatric safety.

Can you take NMN with other supplements or medicines?

The selected studies do not establish a drug-interaction profile. That's not the same as "no interactions."

The linked PubMed search can help locate interaction research [11], but the studies summarized here do not establish NMN's interaction profile alongside common medicines. Tell your clinician and pharmacist everything you take, including other supplements.

If you're thinking of combining it with a NAD+ product, see NMN and NAD+ together.

Does NMN cause weight gain?

The selected trials did not identify a clear weight-gain effect; they cannot rule out an individual change. In the 4-week safety trial, body measurements stayed within normal variation [1]. In older men over 6 to 12 weeks, body composition didn't change [4].

What animal studies add, and don't

Rat studies found no harmful effects at moderate amounts, but very high amounts reduced body weight; rat results don't set a safe human dose.

In a 91-day rat study of one commercial NMN, the highest level without harmful effects was 500 mg per kilogram a day in males and 1,000 in females. At 2,000, rats ate less and gained less weight. The study was written by staff of a testing lab and a US company [10]. Those numbers describe rats; they can't be turned into a human dose.

Product quality is a safety issue too

Because FDA doesn't test supplements before sale, what's in the bottle depends on the maker. The trials used products made for research, often supplied by the company that funded them.

NMN's legal status has also moved. In September 2025, FDA concluded that NMN isn't excluded from the definition of a dietary supplement, reversing its 2022 position, in its primary petition response [12] [13]. Each maker is still responsible for safety and for an accurate label.

Before you buy, check our guide to where to buy NMN and the questions in is NMN legit.

The bottom line

The small trials generally found good short-term tolerability. That does not establish that an individual product or long-term regimen is low-risk for you. If you decide to try it, tell your clinician, keep a list of everything you take, and stop if anything changes that worries you. Whether it's worth taking at all is a separate question, covered in does NMN work and how long NMN takes to work. If you've already stopped, why people stop taking NMN may sound familiar.

Frequently asked

Is NMN dangerous?
Small trials generally report good short-term tolerability. They cannot exclude uncommon harms or establish safety over years, and product quality varies.
Who should not take NMN?
The selected trials do not establish safety in pregnancy, breastfeeding or people with cancer, so those groups should ask a clinician first. The same goes for anyone on regular medicines.
Can I take NMN with other supplements?
The selected studies do not establish an interaction profile. Tell your clinician or pharmacist everything you take.
Does NMN cause weight gain?
Trials that measured weight or body composition found no change.
Is NMN FDA-approved?
No. FDA doesn't approve dietary supplements. Its September 2025 letter found NMN not excluded from the supplement definition; other safety and labeling requirements still apply.

Sources

  1. [1] Fukamizu Y. Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women (2022). PMID 36002548
  2. [2] Irie J. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men (2020). PMID 31685720
  3. [3] Okabe K. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects (2022). PMID 35479740
  4. [4] Igarashi M. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men (2022). PMID 35927255
  5. [5] Yi L. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial (2023). PMID 36482258
  6. [6] Pencina KM. MIB-626, an Oral Formulation of a Microcrystalline Unique Polymorph of β-Nicotinamide Mononucleotide, Increases Circulating Nicotinamide Adenine Dinucleotide and its Metabolome in Middle-Aged and Older Adults (2023). PMID 35182418
  7. [7] Morifuji M. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study (2024). PMID 38789831
  8. [8] Akasaka H. Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study (2023). PMID 36443648
  9. [9] Katayoshi T. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial (2023). PMID 36797393
  10. [10] Turner J. Safety Evaluation for Restorin® NMN, a NAD+ Precursor (2021). PMID 34867355
  11. [11] PubMed search: nicotinamide mononucleotide and drug interactions (accessed October 2026) (2026). Source
  12. [12] FDA response to the NMN citizen petition (September 29, 2025), including prior interpretation and revised supplement exclusion analysis (2025). FDA
  13. [13] Citizen petition on NMN as a dietary supplement, FDA-2023-P-0872 (regulations.gov), including FDA's response of September 29, 2025. FDA

Related research